Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 260

1.

Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification.

La Merrill MA, Vandenberg LN, Smith MT, Goodson W, Browne P, Patisaul HB, Guyton KZ, Kortenkamp A, Cogliano VJ, Woodruff TJ, Rieswijk L, Sone H, Korach KS, Gore AC, Zeise L, Zoeller RT.

Nat Rev Endocrinol. 2019 Nov 12. doi: 10.1038/s41574-019-0273-8. [Epub ahead of print] Review.

PMID:
31719706
2.

The Use and Misuse of Historical Controls in Regulatory Toxicology: Lessons from the CLARITY-BPA Study.

Vandenberg LN, Prins GS, Patisaul HB, Zoeller RT.

Endocrinology. 2019 Nov 6. pii: bqz014. doi: 10.1210/endocr/bqz014. [Epub ahead of print]

PMID:
31690949
3.

Impact of Cognitive Measures and Sleep on Acute Squat Strength Performance and Perceptual Responses Among Well-Trained Men and Women.

Haischer MH, Cooke DM, Carzoli JP, Johnson TK, Shipherd AM, Zoeller RF, Whitehurst M, Zourdos MC.

J Strength Cond Res. 2019 Jul 31. doi: 10.1519/JSC.0000000000003202. [Epub ahead of print]

PMID:
31373979
4.

CLARITY-BPA: Bisphenol A or Propylthiouracil on Thyroid Function and Effects in the Developing Male and Female Rat Brain.

Bansal R, Zoeller RT.

Endocrinology. 2019 Aug 1;160(8):1771-1785. doi: 10.1210/en.2019-00121.

PMID:
31135896
5.

Thyroid hormones and neurobehavioral functions among adolescents chronically exposed to groundwater with geogenic arsenic in Bangladesh.

Khan KM, Parvez F, Zoeller RT, Hocevar BA, Kamendulis LM, Rohlman D, Eunus M, Graziano J.

Sci Total Environ. 2019 Aug 15;678:278-287. doi: 10.1016/j.scitotenv.2019.04.426. Epub 2019 Apr 29.

PMID:
31075594
6.

Update on Activities in Endocrine Disruptor Research and Policy.

Zoeller RT, Doan L, Demeneix B, Gore AC, Nadal A, Tan S.

Endocrinology. 2019 Jul 1;160(7):1681-1683. doi: 10.1210/en.2019-00166.

PMID:
31070722
7.

A cell-based high-throughput screen identifies tyrphostin AG 879 as an inhibitor of animal cell phospholipid and fatty acid biosynthesis.

Zoeller RA, Geoghegan-Barek K.

Biochem Biophys Rep. 2019 Mar 6;18:100621. doi: 10.1016/j.bbrep.2019.100621. eCollection 2019 Jul.

8.

Urinary concentrations of phthalate biomarkers and weight change among postmenopausal women: a prospective cohort study.

Díaz Santana MV, Hankinson SE, Bigelow C, Sturgeon SR, Zoeller RT, Tinker L, Manson JAE, Calafat AM, Meliker JR, Reeves KW.

Environ Health. 2019 Mar 12;18(1):20. doi: 10.1186/s12940-019-0458-6.

9.

Comparative Analyses of the 12 Most Abundant PCB Congeners Detected in Human Maternal Serum for Activity at the Thyroid Hormone Receptor and Ryanodine Receptor.

Sethi S, Morgan RK, Feng W, Lin Y, Li X, Luna C, Koch M, Bansal R, Duffel MW, Puschner B, Zoeller RT, Lehmler HJ, Pessah IN, Lein PJ.

Environ Sci Technol. 2019 Apr 2;53(7):3948-3958. doi: 10.1021/acs.est.9b00535. Epub 2019 Mar 19.

PMID:
30821444
10.

Time course of recovery is similar for the back squat, bench press, and deadlift in well-trained males.

Belcher DJ, Sousa CA, Carzoli JP, Johnson TK, Helms ER, Visavadiya NP, Zoeller RF, Whitehurst M, Zourdos MC.

Appl Physiol Nutr Metab. 2019 Oct;44(10):1033-1042. doi: 10.1139/apnm-2019-0004. Epub 2019 Feb 19.

PMID:
30779596
11.

Body Mass and Femur Length Are Inversely Related to Repetitions Performed in the Back Squat in Well-Trained Lifters.

Cooke DM, Haischer MH, Carzoli JP, Bazyler CD, Johnson TK, Varieur R, Zoeller RF, Whitehurst M, Zourdos MC.

J Strength Cond Res. 2019 Mar;33(3):890-895. doi: 10.1519/JSC.0000000000003021.

PMID:
30640306
12.

Urinary Phthalate Biomarker Concentrations and Postmenopausal Breast Cancer Risk.

Reeves KW, Díaz Santana M, Manson JE, Hankinson SE, Zoeller RT, Bigelow C, Sturgeon SR, Spiegelman D, Tinker L, Luo J, Chen B, Meliker J, Bonner MR, Cote ML, Cheng TD, Calafat AM.

J Natl Cancer Inst. 2019 Oct 1;111(10):1059-1067. doi: 10.1093/jnci/djz002.

PMID:
30629220
13.

Predictors of urinary phthalate biomarker concentrations in postmenopausal women.

Reeves KW, Santana MD, Manson JE, Hankinson SE, Zoeller RT, Bigelow C, Hou L, Wactawski-Wende J, Liu S, Tinker L, Calafat AM.

Environ Res. 2019 Feb;169:122-130. doi: 10.1016/j.envres.2018.10.024. Epub 2018 Oct 30.

PMID:
30447499
14.

Validity of the Open Barbell and Tendo Weightlifting Analyzer Systems Versus the Optotrak Certus 3D Motion-Capture System for Barbell Velocity.

Goldsmith JA, Trepeck C, Halle JL, Mendez KM, Klemp A, Cooke DM, Haischer MH, Byrnes RK, Zoeller RF, Whitehurst M, Zourdos MC.

Int J Sports Physiol Perform. 2019 Apr 1;14(4):540-543. doi: 10.1123/ijspp.2018-0684. Epub 2019 Feb 20.

PMID:
30300064
15.

Maternal Thyroid Function During Pregnancy or Neonatal Thyroid Function and Attention Deficit Hyperactivity Disorder: A Systematic Review.

Drover SSM, Villanger GD, Aase H, Skogheim TS, Longnecker MP, Zoeller RT, Reichborn-Kjennerud T, Knudsen GP, Zeiner P, Engel SM.

Epidemiology. 2019 Jan;30(1):130-144. doi: 10.1097/EDE.0000000000000937.

PMID:
30299402
16.

Effect of Cadence on Time Trial Performance in Recreational Female Cyclists.

Graham PL, Zoeller RF, Jacobs PL, Whitehurst MA.

J Strength Cond Res. 2018 Jun;32(6):1739-1744. doi: 10.1519/JSC.0000000000002044.

PMID:
29786630
17.

A genetic variant in IL-15Rα correlates with physical activity among European-American adults.

Bruneau M Jr, Walsh S, Selinsky E, Ash G, Angelopoulos TJ, Clarkson P, Gordon P, Moyna N, Visich P, Zoeller R, Thompson P, Gordish-Dressman H, Hoffman E, Devaney J, Pescatello LS.

Mol Genet Genomic Med. 2018 May;6(3):401-408. doi: 10.1002/mgg3.368. Epub 2018 Apr 6.

18.

Chemical Probe to Identify the Cellular Targets of the Reactive Lipid Metabolite 2- trans-Hexadecenal.

Jarugumilli GK, Choi JR, Chan P, Yu M, Sun Y, Chen B, Niu J, DeRan M, Zheng B, Zoeller R, Lin C, Wu X.

ACS Chem Biol. 2018 May 18;13(5):1130-1136. doi: 10.1021/acschembio.7b01063. Epub 2018 Apr 6.

19.

Maternal urinary phthalate metabolites during pregnancy and thyroid hormone concentrations in maternal and cord sera: The HOME Study.

Romano ME, Eliot MN, Zoeller RT, Hoofnagle AN, Calafat AM, Karagas MR, Yolton K, Chen A, Lanphear BP, Braun JM.

Int J Hyg Environ Health. 2018 May;221(4):623-631. doi: 10.1016/j.ijheh.2018.03.010. Epub 2018 Mar 23.

20.

A novel assay for the introduction of the vinyl ether double bond into plasmalogens using pyrene-labeled substrates.

Werner ER, Keller MA, Sailer S, Seppi D, Golderer G, Werner-Felmayer G, Zoeller RA, Watschinger K.

J Lipid Res. 2018 May;59(5):901-909. doi: 10.1194/jlr.D080283. Epub 2018 Mar 14.

21.

Polybrominated diphenyl ethers (PBDEs) and hydroxylated PBDE metabolites (OH-PBDEs) in maternal and fetal tissues, and associations with fetal cytochrome P450 gene expression.

Zota AR, Mitro SD, Robinson JF, Hamilton EG, Park JS, Parry E, Zoeller RT, Woodruff TJ.

Environ Int. 2018 Mar;112:269-278. doi: 10.1016/j.envint.2017.12.030. Epub 2018 Jan 6.

22.

Correction to: Parma consensus statement on metabolic disruptors.

Heindel JJ, Vom Saal FS, Blumberg B, Bovolin P, Calamandrei G, Ceresini G, Cohn BA, Fabbri E, Gioiosa L, Kassotis C, Legler J, La Merrill M, Rizzi L, Machtinger R, Mantovani A, Mendez MA, Montanini L, Molteni L, Nagel SC, Parmigiani S, Panzica G, Paterlini S, Pomatto V, Ruzzin J, Sartor G, Schug TT, Street ME, Suvorov A, Volpi R, Zoeller RT, Palanza P.

Environ Health. 2017 Dec 6;16(1):130. doi: 10.1186/s12940-017-0343-0.

23.

Do Environmental Chemicals Make Us Fat?

Zoeller RT, Heindel JJ.

Endocrinology. 2017 Oct 1;158(10):3086-3087. doi: 10.1210/en.2017-00715. No abstract available.

PMID:
28977612
24.

The angiotensin-converting enzyme insertion/deletion polymorphism rs4340 associates with habitual physical activity among European American adults.

Bruneau M Jr, Angelopoulos TJ, Gordon P, Moyna N, Visich P, Zoeller R, Seip R, Bilbie S, Thompson P, Devaney J, Gordish-Dressman H, Hoffman E, Pescatello LS.

Mol Genet Genomic Med. 2017 Jul 2;5(5):524-530. doi: 10.1002/mgg3.308. eCollection 2017 Sep.

25.

The Florence Statement on Triclosan and Triclocarban.

Halden RU, Lindeman AE, Aiello AE, Andrews D, Arnold WA, Fair P, Fuoco RE, Geer LA, Johnson PI, Lohmann R, McNeill K, Sacks VP, Schettler T, Weber R, Zoeller RT, Blum A.

Environ Health Perspect. 2017 Jun 20;125(6):064501. doi: 10.1289/EHP1788.

26.

Effects of Sample Handling and Analytical Procedures on Thyroid Hormone Concentrations in Pregnant Women's Plasma.

Villanger GD, Learner E, Longnecker MP, Ask H, Aase H, Zoeller RT, Knudsen GP, Reichborn-Kjennerud T, Zeiner P, Engel SM.

Epidemiology. 2017 May;28(3):365-369. doi: 10.1097/EDE.0000000000000606.

27.

Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis.

Attina TM, Hauser R, Sathyanarayana S, Hunt PA, Bourguignon JP, Myers JP, DiGangi J, Zoeller RT, Trasande L.

Lancet Diabetes Endocrinol. 2016 Dec;4(12):996-1003. doi: 10.1016/S2213-8587(16)30275-3. Epub 2016 Oct 17.

PMID:
27765541
28.

Scientific principles for the identification of endocrine-disrupting chemicals: a consensus statement.

Solecki R, Kortenkamp A, Bergman Å, Chahoud I, Degen GH, Dietrich D, Greim H, Håkansson H, Hass U, Husoy T, Jacobs M, Jobling S, Mantovani A, Marx-Stoelting P, Piersma A, Ritz V, Slama R, Stahlmann R, van den Berg M, Zoeller RT, Boobis AR.

Arch Toxicol. 2017 Feb;91(2):1001-1006. doi: 10.1007/s00204-016-1866-9. Epub 2016 Oct 6.

29.

Adverse Reproductive and Developmental Health Outcomes Following Prenatal Exposure to a Hydraulic Fracturing Chemical Mixture in Female C57Bl/6 Mice.

Kassotis CD, Bromfield JJ, Klemp KC, Meng CX, Wolfe A, Zoeller RT, Balise VD, Isiguzo CJ, Tillitt DE, Nagel SC.

Endocrinology. 2016 Sep;157(9):3469-81. doi: 10.1210/en.2016-1242. Epub 2016 Aug 25.

30.

Project TENDR: Targeting Environmental Neuro-Developmental Risks The TENDR Consensus Statement.

Bennett D, Bellinger DC, Birnbaum LS, Bradman A, Chen A, Cory-Slechta DA, Engel SM, Fallin MD, Halladay A, Hauser R, Hertz-Picciotto I, Kwiatkowski CF, Lanphear BP, Marquez E, Marty M, McPartland J, Newschaffer CJ, Payne-Sturges D, Patisaul HB, Perera FP, Ritz B, Sass J, Schantz SL, Webster TF, Whyatt RM, Woodruff TJ, Zoeller RT, Anderko L, Campbell C, Conry JA, DeNicola N, Gould RM, Hirtz D, Huffling K, Landrigan PJ, Lavin A, Miller M, Mitchell MA, Rubin L, Schettler T, Tran HL, Acosta A, Brody C, Miller E, Miller P, Swanson M, Witherspoon NO; American College of Obstetricians and Gynecologists (ACOG); Child Neurology Society; Endocrine Society; International Neurotoxicology Association; International Society for Children’s Health and the Environment; International Society for Environmental Epidemiology; National Council of Asian Pacific Islander Physicians; National Hispanic Medical Association; National Medical Association.

Environ Health Perspect. 2016 Jul 1;124(7):A118-22. doi: 10.1289/EHP358. No abstract available.

31.

Peer-reviewed and unbiased research, rather than 'sound science', should be used to evaluate endocrine-disrupting chemicals.

Trasande L, Vandenberg LN, Bourguignon JP, Myers JP, Slama R, Vom Saal F, Zoeller RT.

J Epidemiol Community Health. 2016 Nov;70(11):1051-1056. doi: 10.1136/jech-2016-207841. Epub 2016 Jul 13. Review.

32.

EU regulation of endocrine disruptors: a missed opportunity.

Kortenkamp A, Bourguignon JP, Slama R, Bergman Å, Demeneix B, Ivell R, Panzica G, Trasande L, Zoeller RT.

Lancet Diabetes Endocrinol. 2016 Aug;4(8):649-650. doi: 10.1016/S2213-8587(16)30151-6. Epub 2016 Jul 1. No abstract available.

PMID:
27377541
33.

Science-based regulation of endocrine disrupting chemicals in Europe: which approach?

Bourguignon JP, Slama R, Bergman Å, Demeneix B, Ivell R, Kortenkamp A, Panzica G, Trasande L, Zoeller RT.

Lancet Diabetes Endocrinol. 2016 Aug;4(8):643-646. doi: 10.1016/S2213-8587(16)30121-8. Epub 2016 Jun 14. Review. No abstract available.

34.

Volume-equated high- and low-repetition daily undulating programming strategies produce similar hypertrophy and strength adaptations.

Klemp A, Dolan C, Quiles JM, Blanco R, Zoeller RF, Graves BS, Zourdos MC.

Appl Physiol Nutr Metab. 2016 Jul;41(7):699-705. doi: 10.1139/apnm-2015-0707. Epub 2016 Feb 16.

PMID:
27218448
35.

PBDE flame retardants, thyroid disease, and menopausal status in U.S. women.

Allen JG, Gale S, Zoeller RT, Spengler JD, Birnbaum L, McNeely E.

Environ Health. 2016 May 24;15(1):60. doi: 10.1186/s12940-016-0141-0.

36.

Scientific Issues Relevant to Setting Regulatory Criteria to Identify Endocrine-Disrupting Substances in the European Union.

Slama R, Bourguignon JP, Demeneix B, Ivell R, Panzica G, Kortenkamp A, Zoeller RT.

Environ Health Perspect. 2016 Oct;124(10):1497-1503. Epub 2016 Apr 25.

37.

Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis.

Trasande L, Zoeller RT, Hass U, Kortenkamp A, Grandjean P, Myers JP, DiGangi J, Hunt PM, Rudel R, Sathyanarayana S, Bellanger M, Hauser R, Legler J, Skakkebaek NE, Heindel JJ.

Andrology. 2016 Jul;4(4):565-72. doi: 10.1111/andr.12178. Epub 2016 Mar 22.

38.

Exposure to Thyroid-Disrupting Chemicals: A Transatlantic Call for Action.

Leung AM, Korevaar TI, Peeters RP, Zoeller RT, Köhrle J, Duntas LH, Brent GA, Demeneix BA.

Thyroid. 2016 Apr;26(4):479-80. doi: 10.1089/thy.2016.0077. Epub 2016 Mar 16. No abstract available.

39.

Glucocorticoid Receptor (NR3C1) Variants Associate with the Muscle Strength and Size Response to Resistance Training.

Ash GI, Kostek MA, Lee H, Angelopoulos TJ, Clarkson PM, Gordon PM, Moyna NM, Visich PS, Zoeller RF, Price TB, Devaney JM, Gordish-Dressman H, Thompson PD, Hoffman EP, Pescatello LS.

PLoS One. 2016 Jan 28;11(1):e0148112. doi: 10.1371/journal.pone.0148112. eCollection 2016.

40.

The Path Forward on Endocrine Disruptors Requires Focus on the Basics.

Zoeller RT, Bergman Å, Becher G, Bjerregaard P, Bornman R, Brandt I, Iguchi T, Jobling S, Kidd KA, Kortenkamp A, Skakkebaek N, Toppari J, Vandenberg L.

Toxicol Sci. 2016 Feb;149(2):272. doi: 10.1093/toxsci/kfv329. No abstract available.

PMID:
26811417
41.

EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.

Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, Toppari J, Zoeller RT.

Endocr Rev. 2015 Dec;36(6):E1-E150. doi: 10.1210/er.2015-1010. Epub 2015 Nov 6. Review.

42.

Obesity-Related Genetic Variants and their Associations with Physical Activity.

Lee H, Ash GI, Angelopoulos TJ, Gordon PM, Moyna NM, Visich PS, Zoeller RF, Gordish-Dressman H, Deshpande V, Chen MH, Thompson PD, Hoffman EP, Devaney JM, Pescatello LS.

Sports Med Open. 2015;1(1):34. Epub 2015 Oct 15.

43.

Endocrine-Disrupting Activity of Hydraulic Fracturing Chemicals and Adverse Health Outcomes After Prenatal Exposure in Male Mice.

Kassotis CD, Klemp KC, Vu DC, Lin CH, Meng CX, Besch-Williford CL, Pinatti L, Zoeller RT, Drobnis EZ, Balise VD, Isiguzo CJ, Williams MA, Tillitt DE, Nagel SC.

Endocrinology. 2015 Dec;156(12):4458-73. doi: 10.1210/en.2015-1375. Epub 2015 Oct 14.

PMID:
26465197
44.

Executive Summary to EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.

Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, Toppari J, Zoeller RT.

Endocr Rev. 2015 Dec;36(6):593-602. doi: 10.1210/er.2015-1093. Epub 2015 Sep 28. Review.

45.

Manufacturing doubt about endocrine disrupter science--A rebuttal of industry-sponsored critical comments on the UNEP/WHO report "State of the Science of Endocrine Disrupting Chemicals 2012".

Bergman Å, Becher G, Blumberg B, Bjerregaard P, Bornman R, Brandt I, Casey SC, Frouin H, Giudice LC, Heindel JJ, Iguchi T, Jobling S, Kidd KA, Kortenkamp A, Lind PM, Muir D, Ochieng R, Ropstad E, Ross PS, Skakkebaek NE, Toppari J, Vandenberg LN, Woodruff TJ, Zoeller RT.

Regul Toxicol Pharmacol. 2015 Dec;73(3):1007-17. doi: 10.1016/j.yrtph.2015.07.026. Epub 2015 Jul 31.

46.

NIEHS/FDA CLARITY-BPA research program update.

Heindel JJ, Newbold RR, Bucher JR, Camacho L, Delclos KB, Lewis SM, Vanlandingham M, Churchwell MI, Twaddle NC, McLellen M, Chidambaram M, Bryant M, Woodling K, Gamboa da Costa G, Ferguson SA, Flaws J, Howard PC, Walker NJ, Zoeller RT, Fostel J, Favaro C, Schug TT.

Reprod Toxicol. 2015 Dec;58:33-44. doi: 10.1016/j.reprotox.2015.07.075. Epub 2015 Jul 29. Review.

47.

Attenuated fibroblast growth factor 21 response to acute aerobic exercise in obese individuals.

Slusher AL, Whitehurst M, Zoeller RF, Mock JT, Maharaj M, Huang CJ.

Nutr Metab Cardiovasc Dis. 2015 Sep;25(9):839-45. doi: 10.1016/j.numecd.2015.06.002. Epub 2015 Jun 16.

PMID:
26141939
48.

Parma consensus statement on metabolic disruptors.

Heindel JJ, Vom Saal FS, Blumberg B, Bovolin P, Calamandrei G, Ceresini G, Cohn BA, Fabbri E, Gioiosa L, Kassotis C, Legler J, La Merrill M, Rizzir L, Machtinger R, Mantovani A, Mendez MA, Montanini L, Molteni L, Nagel SC, Parmigiani S, Panzica G, Paterlini S, Pomatto V, Ruzzin J, Sartor G, Schug TT, Street ME, Suvorov A, Volpi R, Zoeller RT, Palanza P.

Environ Health. 2015 Jun 20;14:54. doi: 10.1186/s12940-015-0042-7. Erratum in: Environ Health. 2017 Dec 6;16(1):130.

49.

Response to the Letter by Middlebeek and Veuger.

Bellanger M, Demeneix B, Grandjean P, Zoeller RT, Trasande L.

J Clin Endocrinol Metab. 2015 Jun;100(6):L54-5. doi: 10.1210/jc.2015-2221. No abstract available.

PMID:
26047085
50.

Assessing dose-response relationships for endocrine disrupting chemicals (EDCs): a focus on non-monotonicity.

Zoeller RT, Vandenberg LN.

Environ Health. 2015 May 15;14:42. doi: 10.1186/s12940-015-0029-4.

Supplemental Content

Loading ...
Support Center